Ruth Rappaport
Overview
Explore the profile of Ruth Rappaport including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
575
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Forrest B, Steele A, Hiemstra L, Rappaport R, Ambrose C, Gruber W
Vaccine
. 2011 Mar;
29(20):3633-9.
PMID: 21440036
Background: Although influenza is a major public health concern among adults ≥60 years of age, few large, prospective studies of influenza vaccines have been conducted in this population. The goal...
2.
Lum L, Borja-Tabora C, Breiman R, Vesikari T, Sablan B, Chay O, et al.
Vaccine
. 2009 Dec;
28(6):1566-74.
PMID: 20003918
Children aged 11 to <24 months received 2 intranasal doses of live attenuated influenza vaccine (LAIV) or placebo, 35+/-7 days apart. Dose 1 was administered concomitantly with a combined measles,...
3.
de Villiers P, Steele A, Hiemstra L, Rappaport R, Dunning A, Gruber W, et al.
Vaccine
. 2009 Oct;
28(1):228-34.
PMID: 19796721
This randomized, double-blind, placebo-controlled study investigated the efficacy, safety, and immunogenicity of LAIV in community-dwelling ambulatory adults > or =60 years of age in South Africa in 2001. Nose and...
4.
Breiman R, Brooks W, Goswami D, Lagos R, Borja-Tabora C, Lanata C, et al.
Vaccine
. 2009 Jul;
27(40):5472-9.
PMID: 19616493
Live attenuated influenza vaccine (LAIV) provides a useful tool to rapidly immunize populations in the developing world to prevent influenza outbreaks. In this noninferiority trial conducted in Asia and South...
5.
Forrest B, Pride M, Dunning A, Capeding M, Chotpitayasunondh T, Tam J, et al.
Clin Vaccine Immunol
. 2008 May;
15(7):1042-53.
PMID: 18448618
The highly sensitive gamma interferon (IFN-gamma) enzyme-linked immunosorbent spot (ELISPOT) assay permits the investigation of the role of cell-mediated immunity (CMI) in the protection of young children against influenza. Preliminary...
6.
Tam J, Capeding M, Lum L, Chotpitayasunondh T, Jiang Z, Huang L, et al.
Pediatr Infect Dis J
. 2007 Jun;
26(7):619-28.
PMID: 17596805
Background: This study was designed to evaluate the efficacy and safety of cold-adapted influenza vaccine, trivalent (CAIV-T) against culture-confirmed influenza in children 12 to <36 months of age during 2...
7.
Vesikari T, Fleming D, Aristegui J, Vertruyen A, Ashkenazi S, Rappaport R, et al.
Pediatrics
. 2006 Dec;
118(6):2298-312.
PMID: 17142512
Objective: The goal was to evaluate the safety, tolerability, and efficacy of an investigational, refrigerator-stable formulation of live attenuated influenza vaccine (cold-adapted influenza vaccine-trivalent) against culture-confirmed influenza, acute otitis media,...
8.
Chi X, Li F, Tam J, Rappaport R, Cheng S
J Virol Methods
. 2006 Oct;
139(1):90-2.
PMID: 17030067
A multiplex reverse transcription-polymerase chain reaction (mRT-PCR) method was developed for simultaneous detection and typing/subtyping of influenza viruses A/H1, A/H3 or B, and respiratory syncytial viruses A or B, followed...
9.
Vesikari T, Karvonen A, Korhonen T, Edelman K, Vainionpaa R, Salmi A, et al.
Pediatr Infect Dis J
. 2006 Jun;
25(7):590-5.
PMID: 16804427
Background: Live attenuated influenza vaccine (LAIV; FluMist) is a trivalent vaccine containing cold-adapted influenza vaccine viruses that infect and replicate in cells lining the nasopharynx to induce immunity. Recovery of...
10.
Echavarria M, Maldonado D, Elbert G, Videla C, Rappaport R, Carballal G
J Clin Microbiol
. 2006 Feb;
44(2):625-7.
PMID: 16455929
Adenovirus (AdV) respiratory infections have usually been associated with species B, C, and E. In this study, we detected 9.4% of AdVs by PCR in 500 nasal swabs from 319...